Optimization of Multistage Testing Times and Critical Values in Clinical Trials

DOI10.2307/2532197zbMATH Open0800.62696OpenAlexW2331062220WikidataQ72610218 ScholiaQ72610218MaRDI QIDQ4274356FDOQ4274356

Authors: Erica H. Brittain, Kent R. Bailey 

Publication date: 6 January 1994

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2532197

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited In (4)

• The Influence of Biostatistics at the National Heart, Lung, and Blood Institute
• THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL
• Basic concepts of group sequential and adaptive group sequential test procedures
• Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches

This page was built for publication: Optimization of Multistage Testing Times and Critical Values in Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4274356)